Products
Data
Feature
Plans
Request Demo
Sign Up for Free
Blog
Valuable Targets
Advanced Tech.
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Latest Hotspot
6 min read
BIOTON S.A. Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist
3 August 2026
BIOTON S.A. 2026 BD opportunity scan covering pipeline assets, ownership, stage, transaction precedents, financial signals, IP risk and outreach priorities.
Read →
Latest Hotspot
7 min read
Biosolution Co.,Ltd. Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist
3 August 2026
Biosolution Co.,Ltd. 2026 BD opportunity scan covering pipeline assets, ownership, stage, transaction precedents, financial signals, IP risk and outreach priorities.
Read →
Latest Hotspot
7 min read
Biosceptre International Limited Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist
3 August 2026
Biosceptre International Limited 2026 BD opportunity scan covering pipeline assets, ownership, stage, transaction precedents, financial signals, IP risk and outreach priorities.
Read →
Latest Hotspot
7 min read
Bionomics Limited Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist
3 August 2026
Bionomics Limited 2026 BD opportunity scan covering pipeline assets, ownership, stage, transaction precedents, financial signals, IP risk and outreach priorities.
Read →
Latest Hotspot
7 min read
BIONOVIS S.A. - Companhia Brasileira de Biotecnologia Farmacêutica Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist
3 August 2026
BIONOVIS S.A. - Companhia Brasileira de Biotecnologia Farmacêutica 2026 BD opportunity scan covering pipeline assets, ownership, stage, transaction precedents, financial signals, IP risk and outreach priorities.
Read →
Latest Hotspot
7 min read
Bioneer Corporation Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist
3 August 2026
Bioneer Corporation 2026 BD opportunity scan covering pipeline assets, ownership, stage, transaction precedents, financial signals, IP risk and outreach priorities.
Read →
Latest Hotspot
7 min read
BioMarin Pharmaceutical Inc. Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist
3 August 2026
BioMarin Pharmaceutical Inc. 2026 BD opportunity scan covering pipeline assets, ownership, stage, transaction precedents, financial signals, IP risk and outreach priorities.
Read →
Latest Hotspot
6 min read
BiomX Inc. Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist
3 August 2026
BiomX Inc. 2026 BD opportunity scan covering pipeline assets, ownership, stage, transaction precedents, financial signals, IP risk and outreach priorities.
Read →
Latest Hotspot
7 min read
BioLineRx Ltd. Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist
3 August 2026
BioLineRx Ltd. 2026 BD opportunity scan covering pipeline assets, ownership, stage, transaction precedents, financial signals, IP risk and outreach priorities.
Read →
Latest Hotspot
7 min read
Biolojic Design, Ltd. Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist
3 August 2026
Biolojic Design, Ltd. 2026 BD opportunity scan covering pipeline assets, ownership, stage, transaction precedents, financial signals, IP risk and outreach priorities.
Read →
Latest Hotspot
7 min read
Biohaven Pharmaceutical Holding Company Ltd. Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist
3 August 2026
Biohaven Pharmaceutical Holding Company Ltd. 2026 BD opportunity scan covering pipeline assets, ownership, stage, transaction precedents, financial signals, IP risk and outreach priorities.
Read →
Latest Hotspot
8 min read
Biogen Inc. Company BD Opportunity Scan Report 2026: Pipeline, Deals and Partnering Shortlist
3 August 2026
Biogen Inc. 2026 BD opportunity scan covering pipeline assets, ownership, stage, transaction precedents, financial signals, IP risk and outreach priorities.
Read →
<
1
<<
1777
1778
1779
1780
1781
>>
2926
>